{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:46:33Z","timestamp":1782711993532,"version":"3.54.5"},"reference-count":17,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Patient Related Outcome Measures"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/1179271x.2026.2688849","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:23:13Z","timestamp":1782710593000},"page":"62-75","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the effectiveness of the TURALIO (pexidartinib) risk evaluation and mitigation strategy program: patient knowledge, attitudes, and behavior survey (2020\u20132024)"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3641-9738","authenticated-orcid":false,"given":"Charles","family":"Dharmani","sequence":"first","affiliation":[{"name":"Epidemiology, Clinical Safety and Pharmacovigilance, Daiichi Sankyo Inc, Basking Ridge","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2470-8276","authenticated-orcid":false,"given":"Oluwatosin","family":"Fofah","sequence":"additional","affiliation":[{"name":"Epidemiology, Clinical Safety and Pharmacovigilance, Daiichi Sankyo Inc, Basking Ridge","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3657-6614","authenticated-orcid":false,"given":"Margaret","family":"Wooddell","sequence":"additional","affiliation":[{"name":"Global Oncology Medical Affairs, Daiichi Sankyo Inc","place":["Basking Ridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4848-0689","authenticated-orcid":false,"given":"Janet L.","family":"Ramsey","sequence":"additional","affiliation":[{"name":"Biometrics, United BioSource LLC, King of Prussia","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8159-4109","authenticated-orcid":false,"given":"Michele","family":"Riggen","sequence":"additional","affiliation":[{"name":"Project Management Organization and KAB Programs, United BioSource LLC","place":["King of Prussia, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102491"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020402"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.32074\/1591-951X-213"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60101675"},{"key":"e_1_3_3_7_1","unstructured":"Sankyo D. FDA approves daiichi sankyo\u2019s TURALIO\u2122 (pexidartinib) for the treatment of select patients with TGCT a rare and debilitating tumor. 2019. Available at: https:\/\/daiichisankyo.us\/press-releases\/-\/article\/fda-approves-daiichi-sankyo-s-turalio-pexidartinib-for-the-treatment-of-select-patients-with-tgct-a-rare-and-debilitating-tumor. Accessed December 4 2025."},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-020-00314-3"},{"key":"e_1_3_3_9_1","unstructured":"TURALIO (pexidartinib). for oral use [prescribing information]. Basking Ridge (NJ USA): Daiichi Sankyo Inc; 2025. [cited 2026 Jan 1]. Available from: https:\/\/daiichisankyo.us\/prescribing-information-portlet\/getPIContent?productName=Turalio&inline=true."},{"key":"e_1_3_3_10_1","unstructured":"TURALIO REMS - HOME. Available at: https:\/\/www.turaliorems.com\/. Accessed December 4; 2025."},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14796694.2024.2373687"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021-1475"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2020-0253"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/26.4.404"},{"key":"e_1_3_3_15_1","doi-asserted-by":"crossref","DOI":"10.1002\/0471249688","volume-title":"An Introduction to Categorical Data Analysis","author":"Agresti A.","year":"2002","unstructured":"Agresti A. An Introduction to Categorical Data Analysis. (2nd Edition). John Wiley & Sons, Inc., NJ, USA; 2002.","edition":"2"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-016-0501-2"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad282"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf028"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/14796694.2025.2509409"}],"container-title":["Patient Related Outcome Measures"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1179271X.2026.2688849","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/1179271X.2026.2688849","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1179271X.2026.2688849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:23:16Z","timestamp":1782710596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1179271X.2026.2688849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/1179271X.2026.2688849"],"URL":"https:\/\/doi.org\/10.1080\/1179271x.2026.2688849","relation":{},"ISSN":["1179-271X"],"issn-type":[{"value":"1179-271X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=dpro20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=dpro20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}